$964 Million is the total value of Hikari Power Ltd's 111 reported holdings in Q4 2019. The portfolio turnover from Q3 2019 to Q4 2019 was 48.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
WAT | Sell | WATERS CORPORATION | $9,475,000 | -18.9% | 40,550 | -22.5% | 0.98% | -22.0% |
NVO | Sell | NOVO NORDISK A/Ssponsored adr | $6,766,000 | -38.5% | 116,900 | -45.1% | 0.70% | -40.9% |
PG | Sell | THE PROCTER&GAMBLE COMPANY | $2,170,000 | -65.3% | 17,370 | -65.4% | 0.22% | -66.6% |
GILD | Sell | GILEAD SCIENCES INC | $1,407,000 | -73.6% | 21,650 | -74.3% | 0.15% | -74.7% |
AVXL | Sell | ANAVEX LIFE SCIENCES CORP | $1,112,000 | -24.8% | 429,200 | -8.3% | 0.12% | -28.1% |
ALPN | Sell | ALPINE IMMUNE SCIENCES INC | $712,000 | -3.1% | 185,287 | -0.2% | 0.07% | -6.3% |
SRCL | Sell | STERICYCLE INC | $676,000 | -77.7% | 10,600 | -82.2% | 0.07% | -78.5% |
ZTS | Sell | ZOETIS INC | $609,000 | -45.7% | 4,600 | -48.9% | 0.06% | -47.9% |
GE | Sell | GENERAL ELECTRIC COMPANY | $561,000 | -92.0% | 50,280 | -93.6% | 0.06% | -92.3% |
CRVS | Sell | CORVUS PHARMACEUTICALS INC | $435,000 | +11.3% | 80,000 | -38.5% | 0.04% | +7.1% |
DVA | Sell | DAVITA HEALTHCARE PARTNERS INC | $302,000 | -87.5% | 4,020 | -90.5% | 0.03% | -88.1% |
BIIB | Sell | BIOGEN INC | $252,000 | -92.3% | 850 | -94.0% | 0.03% | -92.7% |
SBPH | Sell | SPRING BANK PHARMACEUTICALS | $207,000 | -62.6% | 131,271 | -18.4% | 0.02% | -65.0% |
MRSN | Exit | MERSANA THERAPEUTICS INC | $0 | – | -90,246 | -100.0% | -0.02% | – |
CALA | Exit | CALITHERA BIOSCIENCES,INC | $0 | – | -50,000 | -100.0% | -0.02% | – |
MDRIQ | Exit | MC DERMOTT INTERNATIONAL,INC | $0 | – | -75,600 | -100.0% | -0.02% | – |
CELG | Exit | CELGENE CORP | $0 | – | -2,080 | -100.0% | -0.02% | – |
TGTX | Exit | TG THERAPEUTICS INC | $0 | – | -50,000 | -100.0% | -0.03% | – |
DNOW | Exit | NOW INC | $0 | – | -55,675 | -100.0% | -0.07% | – |
IFF | Exit | INTL FLAVORS & FRAGRANCES | $0 | – | -5,420 | -100.0% | -0.07% | – |
NOV | Exit | NATIONAL OILWELL VARCO INC | $0 | – | -43,900 | -100.0% | -0.10% | – |
CL | Exit | COLGATE-PALMOLIVE COMPANY | $0 | – | -13,000 | -100.0% | -0.10% | – |
RVNC | Exit | REVANCE THERAPEUTICS INC | $0 | – | -80,100 | -100.0% | -0.11% | – |
EOLS | Exit | EVOLUS INC | $0 | – | -68,500 | -100.0% | -0.12% | – |
UTX | Exit | UNITED TECHNOLOGIES CORP | $0 | – | -14,950 | -100.0% | -0.22% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
- Yasumitsu Shigeta #1
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-02-04
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
CARDINAL HEALTH | 39 | Q3 2023 | 40.7% |
WELLS FARGO & CO NEW | 39 | Q3 2023 | 17.8% |
JOHNSON & JOHNSON | 39 | Q3 2023 | 24.8% |
VISA INC CLASS A | 39 | Q3 2023 | 4.1% |
NOVO-NORDISK A S | 39 | Q3 2023 | 4.2% |
EXXON MOBIL CORPORATION | 39 | Q3 2023 | 3.9% |
NESTLE SA | 39 | Q3 2023 | 3.6% |
COCA COLA CO | 39 | Q3 2023 | 6.4% |
INTUITIVE SURGICAL INC | 39 | Q3 2023 | 2.2% |
BECTON DICKINSON & CO | 39 | Q3 2023 | 2.8% |
View Hikari Power Ltd's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-05-08 |
13F-HR | 2024-01-31 |
13F-HR | 2023-10-26 |
13F-HR | 2023-07-26 |
13F-HR | 2023-04-26 |
13F-HR | 2023-01-25 |
13F-HR | 2022-11-01 |
13F-HR/A | 2022-07-22 |
13F-HR | 2022-07-06 |
13F-HR | 2022-04-13 |
View Hikari Power Ltd's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.